Oscar Health (OSCR) to Release Earnings on Tuesday

Oscar Health (NYSE:OSCR - Get Free Report) is scheduled to be announcing its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Individual interested in listening to the company's earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. Oscar Health's revenue was up 43.9% on a year-over-year basis. During the same period in the previous year, the firm earned ($1.05) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Trading Down 0.2 %

OSCR traded down $0.03 on Tuesday, hitting $17.37. The company had a trading volume of 2,149,276 shares, compared to its average volume of 3,173,583. The firm has a market cap of $3.99 billion, a P/E ratio of -14.50 and a beta of 1.79. Oscar Health has a 1 year low of $4.72 and a 1 year high of $18.55. The company's fifty day moving average price is $15.23 and its 200 day moving average price is $11.41. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on OSCR. Wells Fargo & Company boosted their price target on shares of Oscar Health from $12.00 to $20.00 and gave the stock an "overweight" rating in a research note on Thursday, February 15th. The Goldman Sachs Group upped their target price on shares of Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Raymond James initiated coverage on shares of Oscar Health in a research note on Friday, March 22nd. They set an "outperform" rating and a $20.00 target price on the stock. Finally, TheStreet upgraded shares of Oscar Health from a "d" rating to a "c-" rating in a research note on Wednesday, February 21st. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Oscar Health presently has a consensus rating of "Moderate Buy" and an average target price of $13.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.